GRADIENT MEDICAL, INC.

Cary, NC · Medtech · Private

Phased Algorithmically Controlled Electrotherapy (PACE) system—a minimally invasive medical device using ultrashort high-intensity electrical pulses to treat inoperable liver tumors

gradient-medical.com →
Grants
$1.9M
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Pulsed Electric Field Mediated Intradermal Vaccine Delivery (COVID-19)$255,930
Federal grantDepartment of Health and Human Services · Phase I · Feasibility of INSPIRE Technology to Enhance CRISPR Mediated Genome Editors In Vivo$251,914
Federal grantDepartment of Health and Human Services · Phase I · Feasibility of a Multi-Phase Algorithmic Non-Thermal Ablation Technology for the Treatment of Inoperable Tumors$259,549
Federal grantDepartment of Health and Human Services · Phase II · Commercialization of Algorithmic Non-thermal Ablation Technology for the Treatment of Inoperable Tumors$1,150,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1833ELEVATE ORAL CARE, LLC——
1834MIZAR IMAGING LLC——
1835ALLERGY AMULET, INC.——
1836GRADIENT MEDICAL, INC.——
1837NEUROINDX INC.——
1838NAMI DIAGNOSTICS LLC——
1839ENDOPROTECH, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.